MedPath
HSA Product

FLUDEOXYGLUCOSE [F18] INJECTION 5-200 mCi/mL

Product approved by Health Sciences Authority (SG)

Basic Information

FLUDEOXYGLUCOSE [F18] INJECTION 5-200 mCi/mL

INJECTION, SOLUTION

Regulatory Information

SIN13907P

January 7, 2011

Prescription Only

Therapeutic

INTRAVENOUS

August 10, 2023

May 30, 2025

XV09IX04

Company Information

SINGAPORE RADIOPHARMACEUTICALS PTE. LTD.

SINGAPORE RADIOPHARMACEUTICALS PTE. LTD.

Active Ingredients

2-deoxy-2-[18F]fluoro-D-glucose

Strength: 5-200mCi/mL

© Copyright 2025. All Rights Reserved by MedPath